Clinical Trial Update: Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating ACA 125 in patients with ovarian cancer, focusing on safety and immune response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Neoplasms
• Ovarian Cancer
• Peritoneal Neoplasms

Drugs mentioned

• ACA 125

Snippet

Sponsor: AGO Study Group | Conditions: Ovarian Cancer, Fallopian Tube Neoplasms | Phase 1, Phase 2 | Status: COMPLETED